AHRQ data shows jump in CMS Rx spending

15 April 2009

The US Agency for Healthcare Research and Quality has published data showing a massive increase in Medicare outpatient payments for  prescription medicines, up from $5.9 billion in 2005 to $44.3 billion in  the following year. The figures confirm the effect of the introduction  of the Medicare Part D prescription drug benefit in May 2006  (Marketletters passim). The AHRQ also estimated that the eligible  population saw the following shifts in coverage: Medicare's outgoings  rose from 7% to 45%; Medicaid's fell from 15.5% to 1%; and private  insurers' dropped from 25% to 16.5%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight